Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

5 articles matching "genetic testing"

ResearchPUBMEDApr 16

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Scientists created a new tool called STRIPE that uses advanced genetic testing to read long strands of RNA (the instructions cells use to make proteins). This tool can detect genetic mistakes that cause rare diseases by looking at how genes are actually working in cells, not just finding the mutations themselves. It's designed to be faster, cheaper, and more practical than older methods, which could help doctors diagnose rare genetic diseases that are hard to identify.

WHY IT MATTERSPatients with undiagnosed rare genetic diseases could finally get answers through more accurate genetic testing, since STRIPE can detect disease-causing variants that standard DNA tests might miss.
Good to knowRead →
ResearchCONGRESSApr 1

AAN 2026: Social Determinants of Health, the Diagnostic Odyssey, and Genetic Testing for Global Developmental Delay/Intellectual Disability: A Qualitative Study.

Researchers studied how life circumstances like poverty, access to healthcare, and education affect children with developmental delays and intellectual disabilities. They also looked at how long it takes families to get a diagnosis and whether genetic testing helps. The study suggests that where you live and your resources matter a lot in getting answers for why a child has developmental challenges.

WHY IT MATTERSThis research highlights that children from disadvantaged backgrounds face longer diagnostic journeys for developmental delays—meaning families may wait years longer to understand their child's condition and access support services.
Good to knowGlobal Developmental DelayIntellectual DisabilityRead →
ResearchPUBMEDApr 1

Expanding Access to Genome Sequencing: Higher Diagnostic Yield in Self-Referred Participants From the CincyKidsSeq Study and Implications for Hybrid Models of Genetic Service Delivery.

Researchers tested whether people could get genetic testing (genome sequencing) without always needing to see a genetics specialist first. They studied 313 people of all ages who had unexplained symptoms and could refer themselves or be referred by any doctor. The study found that people who referred themselves were just as likely to get a diagnosis as those referred by specialists. This suggests a new way to make genetic testing available to more people while still having genetics experts review the results.

WHY IT MATTERSIf this hybrid model works, patients with rare diseases could access genome sequencing faster and more easily without waiting for a genetics specialist appointment, potentially shortening the diagnostic odyssey that many rare disease patients experience.
💬 Ask your doctorrare genetic diseasesundiagnosed genetic conditionsRead →
ResearchPUBMEDMar 26

[Resolving Genomic Mysteries with Long-read Sequencing].

Scientists are using a new technology called long-read sequencing that can read much longer pieces of DNA than older methods. This helps doctors find genetic causes of rare diseases that were previously missed, especially when mutations hide in repetitive parts of the genome or involve large structural changes. The technology is becoming an important tool in genetic testing labs worldwide.

WHY IT MATTERSIf you have a rare genetic disease that wasn't diagnosed by standard genetic testing, long-read sequencing may finally identify the genetic cause—potentially opening doors to targeted treatments and genetic counseling for your family.
💬 Ask your doctorRare genetic diseasesGenetic disorders with structural variantsInborn genetic diseasesRead →
ResearchCLINICALTRIALSMar 26

Trial Now Recruiting: Genetic Analysis of Uncommon Disease Presentations in Non-US Populations (NCT06595940)

Researchers are looking for genetic causes of rare and unusual diseases in people living outside the United States who haven't had access to genetic testing. They're using new, powerful tools to study the DNA of about 400 people to find out what's causing their diseases. This study could help doctors understand and diagnose rare conditions that are hard to figure out.

WHY IT MATTERSThis trial focuses on underserved populations outside the US with limited access to genetic testing, potentially identifying new disease-causing genes that could lead to diagnoses for patients who have remained undiagnosed despite extensive medical evaluation.
You can act on thisUndiagnosed DiseasesRare DiseasesRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases